Clinical, Virological and Safety Outcomes of a Lopinavir/Ritonavir-Based Regimen in HIV-1 Infected Patients in Routine Clinical Use in China
NCT01074931
·
clinicaltrials.gov ↗
COMPLETED
Status
98
Enrollment
INDUSTRY
Sponsor class
Conditions
HIV-1 Infections
Interventions
DRUG:
Lopinavir/ritonavir (Kaletra)
Sponsor
Abbott